世界*實(shí)驗材料供應(yīng)商innavative Research 正式授權(quán)上海起發(fā)為其中國代理，innavative Research 在一直是行業(yè)的*,一直為廣大科研客戶提供zui為的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國科研客戶帶來的產(chǎn)品，的服務(wù)， 簽約innavative Research 就是為了給廣大科研客戶帶來更加完善的產(chǎn)品和服務(wù),您的滿意將是我們zui大的收獲

innavative Research 中國代理，innavative Research 上海代理，innavative Research 北京代理，innavative Research 廣東代理，innavative Research 江蘇代理 innavative Research 湖北代理, innavative Research 天津, innavative Research 黑龍江代理, innavative Research 內(nèi)蒙古代理, innavative Research 吉林代理, innavative Research 福建代理, innavative Research 江蘇代理, innavative Research 浙江代理, innavative Research 四川代理,

For a third of a century, Innovative Research of America has assumed the leadership role in improved time release technology. The main mission is to standardize the technology of drug delivery. Our proven Time Release Hormone and Drug Pellets help investigators take charge of product delivery and expand their abilities to do meaningful and reproducible research.

The Research Problem

Since it is not easy to administer drugs and hormones orally to research animals, several delivery methods have been devised as alternatives. However, most scientists continue to labor with unreliable injectables to conduct their research.

Because of this inadequacy, biomedical research is as confusing as it is challenging and as frustrating as it is creative. The options of scientists to address scientific questions are not only dependent, but are also limited by the process of active product delivery. Traditionally, product delivery into the experimental animal has been the procedure most subject to variables and the most difficult to standardize effectively. The very process of having to accuray administer drugs to experimental animals can become a logistic nightmare for scientists.

The Research Solution:  Changing The Time Course Of Drug Delivery

The good news is that times have changed. Our proven Drug Delivery Technology is helping investigators eliminate the need for unreliable, intermittent injections. Since 1980, Innovative Research of America has been the leader in supplying scientists with long term continuous release pellets embedded with active products. Our technology provides finished products, in a ready-to-implant form, utilizing our Matrix-Driven Delivery (MDD) Pellet System. The pellets are intended for, although not limited to, simple subcutaneous implantation in laboratory animals.

The unique engineering of the (MDD) Pellet System integrates the three principles of diffusion, erosion and concentration gradients. It generates a finished pellet with a biodegradable matrix that effectively and continuously releases the active product in the animal.

The pellet delivery system can help the investigator take charge of standardizing and reproducing research results. It helps overcome problems commonly encountered by researchers who employ conventional delivery methods.

Scientists from several research disciplines have documented in scientific literature that our Pellet Delivery System is effective, consistent, reproducible, economical, reliable, and safe for the animal. For a select list of published literature please visit ourreferences page.

我們公司zui大優(yōu)勢是強(qiáng)大的采購，

1：基本什么都能進(jìn)口，血清，抗體，耗材，還有部分限制進(jìn)口的，

2： 貨品全，現(xiàn)經(jīng)營過700多個品牌，基本所有生物試劑耗材都可以進(jìn)口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢，

3：提供加急服務(wù)，一般1-2周到貨，超過時限加急費(fèi)全免

4：價格公道，絕大部分價格有優(yōu)勢，當(dāng)然不能保證100%產(chǎn)品都是,因為意味著沒有服務(wù).

5：良好的信譽(yù)，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大 交大 復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國藥 ，fisher等500多家公司

6：我們還是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America； Ludger ； neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO；quickzyme；RESEARCH DIETS, INC；sterlitech；sysy；TriLink BioTechnologies, Inc；worthington-biochem;zyagen;......幾十家國外公司授權(quán)代理

7：我們還從事invitrogen，qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend....等*批發(fā)